Altria Group Boosts EPS Guidance, Sets Stage for Next Dividend Hike
ByAinvest
Monday, Aug 4, 2025 8:32 am ET1min read
MO--
Altria Group (MO) recently raised its earnings per share (EPS) guidance, signaling a positive outlook for the company. Despite initial concerns about the declining tobacco industry, a closer look at Altria's financials reveals promising prospects. The company's adjusted EPS for the second quarter of 2025 climbed 8.3% to $1.44, surpassing analyst expectations [1].
Altria's revenue net of excise taxes fell 1.7% to $5.29 billion, while adjusted EPS climbed 8.3% to $1.44. The company's oral nicotine pouches, which compete with Philip Morris International's Zyn, saw strong growth, with shipment volumes climbing 26.5% to 52.1 million cans. Revenue in this segment rose 6% to $728 million. However, the company's cigarette business continues to experience large shipment declines, with overall shipment volumes down 10.2% [1].
Looking ahead, Altria raised the low end of its full-year adjusted EPS outlook to $5.35 to $5.45, representing 3% to 5% growth. This is up from a prior range of $5.30 to $5.45. The company's dividend remains attractive, with a current payout of $1.02 per quarter, or an annual rate of $4.08. However, through the first six months of the year, Altria's cash flows were not covering its dividend payout, which can be a red flag [1].
Despite these concerns, Altria's balance sheet remains healthy, with debt-to-EBITDA leverage of 2 times, which is reasonable. The company's transition towards smoke-free products, such as oral nicotine pouches, shows promise in offsetting declines in cigarette sales. Moreover, Altria's Njoy e-vapor business, despite patent disputes, continues to innovate with new product designs [1].
Investors should consider Altria's strong dividend history and the potential for continued growth in non-cigarette segments. However, the company's core business continues to face significant headwinds, and the sustainability of its dividend remains a concern. Altria's valuation, with a forward price-to-earnings (P/E) ratio of 11.5, appears attractive compared to its international counterpart, Philip Morris International [1].
In conclusion, Altria Group's recent EPS guidance increase signals a positive outlook, but investors should remain cautious about the company's core business and the sustainability of its dividend. The company's transition towards smoke-free products offers promising growth prospects, but the tobacco industry's regulatory challenges and declining consumer demand remain significant risks.
References
[1] https://www.fool.com/investing/2025/08/03/altria-has-a-big-dividend-yield-but-is-it-sustaina/
[2] https://seekingalpha.com/article/4808246-altria-group-raised-eps-guidance-exciting-next-potential-dividend-increase
Altria Group raised its EPS guidance, indicating a positive outlook for the company. Investors initially overlooked the company's potential due to the decline of the tobacco industry. However, a closer look at the financials reveals a promising future for the company.
Title: Altria Group Raises EPS Guidance, Indicating Positive OutlookAltria Group (MO) recently raised its earnings per share (EPS) guidance, signaling a positive outlook for the company. Despite initial concerns about the declining tobacco industry, a closer look at Altria's financials reveals promising prospects. The company's adjusted EPS for the second quarter of 2025 climbed 8.3% to $1.44, surpassing analyst expectations [1].
Altria's revenue net of excise taxes fell 1.7% to $5.29 billion, while adjusted EPS climbed 8.3% to $1.44. The company's oral nicotine pouches, which compete with Philip Morris International's Zyn, saw strong growth, with shipment volumes climbing 26.5% to 52.1 million cans. Revenue in this segment rose 6% to $728 million. However, the company's cigarette business continues to experience large shipment declines, with overall shipment volumes down 10.2% [1].
Looking ahead, Altria raised the low end of its full-year adjusted EPS outlook to $5.35 to $5.45, representing 3% to 5% growth. This is up from a prior range of $5.30 to $5.45. The company's dividend remains attractive, with a current payout of $1.02 per quarter, or an annual rate of $4.08. However, through the first six months of the year, Altria's cash flows were not covering its dividend payout, which can be a red flag [1].
Despite these concerns, Altria's balance sheet remains healthy, with debt-to-EBITDA leverage of 2 times, which is reasonable. The company's transition towards smoke-free products, such as oral nicotine pouches, shows promise in offsetting declines in cigarette sales. Moreover, Altria's Njoy e-vapor business, despite patent disputes, continues to innovate with new product designs [1].
Investors should consider Altria's strong dividend history and the potential for continued growth in non-cigarette segments. However, the company's core business continues to face significant headwinds, and the sustainability of its dividend remains a concern. Altria's valuation, with a forward price-to-earnings (P/E) ratio of 11.5, appears attractive compared to its international counterpart, Philip Morris International [1].
In conclusion, Altria Group's recent EPS guidance increase signals a positive outlook, but investors should remain cautious about the company's core business and the sustainability of its dividend. The company's transition towards smoke-free products offers promising growth prospects, but the tobacco industry's regulatory challenges and declining consumer demand remain significant risks.
References
[1] https://www.fool.com/investing/2025/08/03/altria-has-a-big-dividend-yield-but-is-it-sustaina/
[2] https://seekingalpha.com/article/4808246-altria-group-raised-eps-guidance-exciting-next-potential-dividend-increase

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet